Top compounds associated with response to MBD1


Feature Type Standardized
Nominal ANOVA
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC 0.17 2e-05
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 2e-05
mRNA prima-1 CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA NSC632839 CTRPv2 pan-cancer AAC 0.16 4e-05
mRNA BRD-K52037352 CTRPv2 pan-cancer AAC 0.18 4e-05
mRNA SID 26681509 CTRPv2 pan-cancer AAC 0.17 5e-05
mRNA PL-DI CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA PF-184 CTRPv2 pan-cancer AAC 0.15 7e-05
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 7e-05
mRNA Cerulenin CTRPv2 pan-cancer AAC 0.15 7e-05
Download CSV